Showing results (141-150 of 317) with videos related to

Sort By:
Pageof 32
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Immune biomarkers for head and neck cancerNavid Sobhani, Alberto D'Angelo, Fernanda G Kugeratski, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of LiteratureOttavia Bernocchi, Marianna Sirico, Silvia Paola Corona, et al.
Expert Review of Gastroenterology & Hepatology|July 5, 2016
Apatinib for the treatment of gastric cancerGiandomenico Roviello, Andrea Ravelli, Anna Ida Fiaschi, et al.
Future Oncology (London, England)|February 13, 2015
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practiceAlessandra Fabi, Luca Moscetti, Mariangela Ciccarese, et al.
Tumori|January 6, 2022
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trialBenedetta Conte, Filippo Montemurro, Alessia Levaggi, et al.
Clinical Medicine Insights. Reproductive Health|August 9, 2019
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A ReviewFrancesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
Plos One|July 5, 2013
Triple negative breast cancers have a reduced expression of DNA repair genesEnilze Ribeiro, Monica Ganzinelli, Daniele Andreis, et al.
British Journal of Cancer|November 28, 2018
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefitTiziana Triulzi, Viola Regondi, Loris De Cecco, et al.
ESMO Open|June 27, 2018
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysisFrancesca Poggio, Marco Bruzzone, Marcello Ceppi, et al.
Anticancer Research|July 2, 2014
Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancerAlessia Levaggi, Andrea De Maria, Beatrice Dozin, et al.
Pageof 32